Compare Eli Lilly And Co (LLY) vs PubMatic Inc (PUBM) Price & Performance

Eli Lilly And CoTrade

PubMatic IncTrade

Price performance (Past 24H)

Key statistics

Eli Lilly And Co vs PubMatic Inc — how do they compare? Eli Lilly And Co trades at $1,162.51 (market cap $1.02T), while PubMatic Inc trades at $12.83 (market cap $607.48M). The key difference: Eli Lilly And Co is far larger — about 1679.1× PubMatic Inc's market cap, and Eli Lilly And Co pays a 0.6% dividend while PubMatic Inc pays none. Which is the better fit depends on your goals.

	LLY	PUBM
Market Cap	$1.02T	$607.48M
Sector	Health	Technology
52-Week High	$1.24K	$13.83
52-Week Low	$625.65	$6.28
Enterprise Value	$1.06T	$504.98M
Dividend Yield	0.6%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eli Lilly And Co

No Aura AI signal available yet.

PubMatic Inc

PUBM trades at $13.07, up 2.67% today, with a bullish technical signal from moving averages and oversold RSI conditions. The company reported a net loss of -$14.46M in 2025 despite beating Q1 2026 EPS estimates, with revenue at $282.93M. Recent news highlights product launches like AgenticOS and partnerships expanding its AI-powered ad tech reach, while analyst consensus is evenly split between Buy and Hold.

The outlook is mixed: strong cash flow and innovation in AI advertising support growth potential, but persistent negative margins and high P/E of 132 pose valuation risks. Upside exists if upcoming Q2 2026 earnings beat expectations, though competitive and macroeconomic pressures remain headwinds for profitability.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LLY

Novo Nordisk sues Eli Lilly over misleading ads on obesity and diabetes drug efficacy.CNBC · 6 hours agoBearish Atlas Healthcare Fund's 2020 Eli Lilly bet soared 246%, showcasing early clinical insight in healthcare investing.Vst Capital · 4 days agoBullish Healthcare ETF TMED jumps 18.6% YTD, driven by strong pharma stocks like Eli Lilly.ETF Trends · 4 days agoBullish View details →

PUBM

View details →

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

About PubMatic Inc

PubMatic Inc is engaged in the digital advertising business. The company provides a specialized cloud infrastructure platform that enables real-time programmatic advertising transactions. The platform helps independent app developers and publishers to control and maximize their digital advertising businesses.